Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?

Cancer statistics, 2020

Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444 · see citing works

mTOR Signaling in Growth Control and Disease

Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · see citing works

mTOR Signaling in Growth, Metabolism, and Disease

Saxton, R. A., & Sabatini, D. M. (2017) · Cell · doi:10.1016/j.cell.2017.02.004 · Cited by 7,555 · see citing works

Wnt/β-catenin signaling and disease

Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554 · see citing works

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works

Lessons from hereditary colorectal cancer

Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919 · see citing works

Identification of c- <i>MYC</i> as a Target of the APC Pathway

He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566 · see citing works

β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · see citing works

High Frequency of Mutations of the PIK3CA Gene in Human Cancers

Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448 · see citing works

mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Kim, D.-H., Sarbassov, D., Ali, S. M., King, J. E., Latek, R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,135 · see citing works

TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083 · see citing works

Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Alessi, D., James, S., Downes, C., Holmes, A. B., Gaffney, P., Reese, C., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 3,047 · see citing works

Functional interaction of β-catenin with the transcription factor LEF-1

Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912 · see citing works

Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton

Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665 · see citing works

β‐catenin is a target for the ubiquitin–proteasome pathway

Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,533 · see citing works

Identification of FAP Locus Genes from Chromosome 5q21

Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,331 · see citing works

The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway

Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230 · see citing works

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

De Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G., Kalogeras, K. T., Kotoula, V., Papamichael, D., Laurent-Puig, P., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70130-3 · Cited by 2,144 · see citing works

eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation

Gingras, A., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,103 · see citing works

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

Huang, S.-M. A., Mishina, Y., Liu, S.-M., Cheung, A. K., Stegmeier, F., Michaud, G., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,077 · see citing works

Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism

Liu, C., Li, Y., Semënov, M. V., Han, C., Baeg, G., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,066 · see citing works

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling

Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes &amp; Development · doi:10.1101/gad.1110003 · Cited by 1,911 · see citing works

Mutations of Chromosome 5q21 Genes in FAP and Colorectal Cancer Patients

Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., Hedge, P., et al. (1991) · Science · doi:10.1126/science.1651563 · Cited by 1,891 · see citing works

XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos

Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824 · see citing works

Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway

Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555 · see citing works

A new member of the frizzled family from Drosophila functions as a Wingless receptor

Bhanot, P., van den Brink, M. R. M., Samos, C. H., Hsieh, J.-C., Wang, Y., Macke, J. P., Andrew, D. J., Nathans, J., & Nusse, R. (1996) · Nature · doi:10.1038/382225a0 · Cited by 1,504 · see citing works

Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly

Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C. J., Munemitsu, S. M., & Polakis, P. G. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,420 · see citing works

Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer

Chen, B., Dodge, M. E., Tang, W., Lü, J., Ma, Z., Fan, C.-W., Wei, S., Hao, W., Kilgore, J. A., Williams, N. S., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.137 · Cited by 1,385 · see citing works

TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth

Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377 · see citing works

LDL-receptor-related proteins in Wnt signal transduction

Tamai, K., Semënov, M. V., Kato, Y., Spokony, R. F., Liu, C., Katsuyama, Y., Hess, F. J., Saint‐Jeannet, J., & He, X. (2000) · Nature · doi:10.1038/35035117 · Cited by 1,334 · see citing works

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

Carpten, J. D., Faber, A. L., Horn, C. L., Donoho, G. P., Briggs, S., Robbins, C. M., Hostetter, G. H., Boguslawski, S. J., Moses, T. Y., Savage, S., et al. (2007) · Nature · doi:10.1038/nature05933 · Cited by 1,291 · see citing works

mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events

Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005) · Cell · doi:10.1016/j.cell.2005.10.024 · Cited by 1,262 · see citing works

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin

Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., & Kikuchi, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,248 · see citing works

Association of the APC Gene Product with β-Catenin

Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S. M., & Polakis, P. G. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · see citing works

Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward Rheb

Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C., & Blenis, J. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00506-2 · Cited by 1,211 · see citing works

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

Peterson, T. R., Laplante, M., Thoreen, C. C., Sancak, Y., Kang, S. A., Kuehl, W. M., Gray, N. S., & Sabatini, D. M. (2009) · Cell · doi:10.1016/j.cell.2009.03.046 · Cited by 1,202 · see citing works

Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors

Lustig, B., Jerchow, B., Sachs, M., Weiler, S., Pietsch, T., Karsten, U., van de Wetering, M., Clevers, H., Schlag, P., Birchmeier, W., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1184-1193.2002 · Cited by 1,198 · see citing works

Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

Haar, E. V., Lee, S.-I., Bandhakavi, S., Griffin, T. J., & Kim, D. (2007) · Nature Cell Biology · doi:10.1038/ncb1547 · Cited by 1,185 · see citing works

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin, S., Frasson, C., Basso, G., Guzzardo, V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.013 · Cited by 1,094 · see citing works

An LDL-receptor-related protein mediates Wnt signalling in mice

Pinson, K. I., Brennan, J., Monkley, S. J., Avery, B. J., & Skarnes, W. C. (2000) · Nature · doi:10.1038/35035124 · Cited by 1,086 · see citing works

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3870 · Cited by 1,079 · see citing works

The LKB1 tumor suppressor negatively regulates mTOR signaling

Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,067 · see citing works

The emerging roles of forkhead box (Fox) proteins in cancer

Myatt, S. S., & Lam, E. W. ‐. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2223 · Cited by 1,065 · see citing works

The -Catenin Destruction Complex

Stamos, J. L., & Weis, W. I. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007898 · Cited by 1,062 · see citing works

Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors

Koo, B., Spit, M., Jordens, I., Low, T. Y., Stange, D. E., van de Wetering, M., van Es, J. H., Mohammed, S., Heck, A. J. R., Maurice, M. M., et al. (2012) · Nature · doi:10.1038/nature11308 · Cited by 991 · see citing works

ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner

Hao, H.-X., Xie, Y., Zhang, Y., Charlat, O., Oster, E., Avello, M., Lei, H., Mickanin, C., Liu, D., Ruffner, H., et al. (2012) · Nature · doi:10.1038/nature11019 · Cited by 962 · see citing works

GβL, a Positive Regulator of the Rapamycin-Sensitive Pathway Required for the Nutrient-Sensitive Interaction between Raptor and mTOR

Kim, D., Sarbassov, D. D., Ali, S. M., Latek, R. R., Guntur, K., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00114-x · Cited by 955 · see citing works

Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex

Li, V. S. W., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J. R., Maurice, M. M., Mahmoudi, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.002 · Cited by 889 · see citing works

4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathwayPreprint

Gingras, A., Kennedy, S. G., O'Leary, M., Sonenberg, N., & Hay, N. (1998) · Genes & Development · doi:10.1101/gad.12.4.502 · Cited by 885 · see citing works

A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation

Zeng, X., Tamai, K., Doble, B. W., Li, S., Huang, H., Habas, R., Okamura, H., Woodgett, J. R., & He, X. (2005) · Nature · doi:10.1038/nature04185 · Cited by 849 · see citing works

Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974

Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 836 · see citing works

Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β

Hart, M. J., Santos, R. D. L., Albert, I., Rubinfeld, B., & Polakis, P. G. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70226-x · Cited by 836 · see citing works

Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion.

Takada, R., Satomi, Y., Kurata, T., Ueno, N., Norioka, S., Kondoh, H., Takao, T., & Takada, S. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.003 · Cited by 807 · see citing works

Activation of Akt and eIF4E Survival Pathways by Rapamycin-Mediated Mammalian Target of Rapamycin Inhibition

Sun, S., Rosenberg, L. M., Wang, X., Zhou, Z., Yue, P., Fu, H., & Khuri, F. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0917 · Cited by 800 · see citing works

Alternative Wnt Signaling Activates YAP/TAZ

Park, H. W., Kim, Y. C., Yu, B., Moroishi, T., Mo, J., Plouffe, S. W., Meng, Z., Lin, K. C., Yu, F., Alexander, C. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.013 · Cited by 708 · see citing works

The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway

Lee, E., Salic, A., Krüger, R., Heinrich, R., & Kirschner, M. W. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000010 · Cited by 708 · see citing works

A Common Phosphate Binding Site Explains the Unique Substrate Specificity of GSK3 and Its Inactivation by Phosphorylation

Frame, S., Cohen, P., & Biondi, R. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00253-2 · Cited by 703 · see citing works

mSin1 Is Necessary for Akt/PKB Phosphorylation, and Its Isoforms Define Three Distinct mTORC2s

Frías, M. A., Thoreen, C. C., Jaffe, J. D., Schroder, W. A., Sculley, T. B., Carr, S. A., & Sabatini, D. M. (2006) · Current Biology · doi:10.1016/j.cub.2006.08.001 · Cited by 690 · see citing works

Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation.

Beretta, L., Gingras, A., Svitkin, Y. V., Hall, M. N., & Sonenberg, N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00398.x · Cited by 678 · see citing works

Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis

McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600633 · Cited by 594 · see citing works

The Hippo Pathway Regulates Wnt/β-Catenin Signaling

Varelas, X., Miller, B. W., Sopko, R., Song, S., Gregorieff, A., Fellouse, F. A., Sakuma, R., Pawson, T. J., Hunziker, W., McNeill, H., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.03.007 · Cited by 571 · see citing works

An F‐box protein, FWD1, mediates ubiquitin‐dependent proteolysis of β‐catenin

Kitagawa, M., Hatakeyama, S., Shirane, M., Matsumoto, M., Ishida, N., Hattori, K., Nakamichi, I., Kikuchi, A., Nakayama, K.-I., & Nakayama, K. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2401 · Cited by 529 · see citing works

GSK-3: Functional Insights from Cell Biology and Animal Models

Kaidanovich‐Beilin, O., & Woodgett, J. R. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00040 · Cited by 487 · see citing works

Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains

Dann, C. E., Hsieh, J.-C., Rattner, A., Sharma, D., Nathans, J., & Leahy, D. J. (2001) · Nature · doi:10.1038/35083601 · Cited by 473 · see citing works

PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers

Wee, S., Jagani, Z., Xiang, K. X., Loo, A., Dorsch, M., Yao, Y.-M., Sellers, W. R., Lengauer, C., & Stegmeier, F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4765 · Cited by 455 · see citing works

Functional Redundancy of GSK-3α and GSK-3β in Wnt/β-Catenin Signaling Shown by Using an Allelic Series of Embryonic Stem Cell Lines

Doble, B. W., Patel, S., Wood, G. A., Kockeritz, L. K., & Woodgett, J. R. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.001 · Cited by 449 · see citing works

Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt Signaling

Ding, V. W., Chen, R., & McCormick, F. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005342200 · Cited by 428 · see citing works

Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer

Cheng, X., Xu, X., Chen, D., Zhao, F., & Wang, W. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.082 · Cited by 420 · see citing works

β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

Tenbaum, S. P., Ordóñez‐Morán, P., Puig, I., Chicote, I., Arqués, O., Landolfi, S., Fernández, Y., Herance, J. R., Gispert, J. D., Mendizabal, L., et al. (2012) · Nature Medicine · doi:10.1038/nm.2772 · Cited by 386 · see citing works

Akt-dependent and -independent mechanisms of mTOR regulation in cancer

Memmott, R. M., & Dennis, P. A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.004 · Cited by 383 · see citing works

Wnt signals across the plasma membrane to activate the β-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP

Cong, F., Schweizer, L., & VARMUS, H. E. (2004) · Development · doi:10.1242/dev.01318 · Cited by 364 · see citing works

Wnt signaling in adult intestinal stem cells and cancer

Krausová, M., & Kořínek, V. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.032 · Cited by 362 · see citing works

Activation of AXIN2 Expression by β-Catenin-T Cell Factor

Leung, J. Y., Kolligs, F. T., WU, R. T., Zhai, Y., Kuick, R. D., Hanash, S., Cho, K. R., & Fearon, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200139200 · Cited by 352 · see citing works

Mutations in the RAS‐MAPK, PI(3)K (phosphatidylinositol‐3‐OH kinase) signaling network correlate with poor survival in a population‐based series of colon cancers

Barault, L., Veyrie, N., Jooste, V., Corre, D. L., Chapusot, C., Ferraz, J., Lièvre, A., Cortet, M., Bouvier, A., Rat, P., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23388 · Cited by 345 · see citing works

Wnt addiction of genetically defined cancers reversed by PORCN inhibition

Madan, B., Ke, Z., Harmston, N., Ho, S. Y., Frois, A. O., Alam, J., Jeyaraj, D. A., Pendharkar, V. V., Ghosh, K., Virshup, I., et al. (2015) · Oncogene · doi:10.1038/onc.2015.280 · Cited by 342 · see citing works

Mutation Profiling and Microsatellite Instability in Stage II and III Colon Cancer: An Assessment of Their Prognostic and Oxaliplatin Predictive Value

Gavin, P. G., Colangelo, L. H., Fumagalli, D., Tanaka, N., Remillard, M. Y., Yothers, G., Kim, C., Taniyama, Y., Kim, S. I., Choi, H. J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0605 · Cited by 320 · see citing works

A Novel Tankyrase Small-Molecule Inhibitor Suppresses <i>APC</i> Mutation–Driven Colorectal Tumor Growth

Lau, T., Chan, E., Callow, M., Waaler, J., Boggs, J., Blake, R. A., Magnuson, S., Sambrone, A., Schutten, M., Firestein, R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4562 · Cited by 316 · see citing works

S6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of Akt

Zhang, H. H., Lipovsky, A. I., Dibble, C. C., Şahin, M., & Manning, B. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.09.019 · Cited by 309 · see citing works

mTORC1-mediated translational elongation limits intestinal tumour initiation and growth

Faller, W. J., Jackson, T. J., Knight, J. R. P., Ridgway, R. A., Jamieson, T. J., Karim, S. A., Jones, C., Radulescu, S., Huels, D. J., Myant, K., et al. (2014) · Nature · doi:10.1038/nature13896 · Cited by 302 · see citing works

Frequent Inactivation of PTEN by Promoter Hypermethylation in Microsatellite Instability-High Sporadic Colorectal Cancers

Goel, A., Arnold, C. N., Niedzwiecki, D., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., & Boland, C. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2401-2 · Cited by 302 · see citing works

TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin

Zheng, X.-F., Fiorentino, D. F., Chen, J., Crabtree, G. R., & Schreiber, S. L. (1995) · Cell · doi:10.1016/0092-8674(95)90058-6 · Cited by 300 · see citing works

Wnt/β-Catenin Signaling Regulates Yes-associated Protein (YAP) Gene Expression in Colorectal Carcinoma Cells

Raup‐Konsavage, W. M., Kyler, S. L., Rennoll, S. A., Jin, G., & Yochum, G. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327767 · Cited by 277 · see citing works

Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship

Jhanwar-Uniyal, M., Wainwright, J. V., Mohan, A. L., Tobias, M. E., Murali, R., Gandhi, C. D., & Schmidt, M. H. (2019) · Advances in Biological Regulation · doi:10.1016/j.jbior.2019.03.003 · Cited by 268 · see citing works

Phosphorylation of the Eukaryotic Translation Initiation Factor eIF4E Contributes to Its Transformation and mRNA Transport Activities

Topisirovic, I., Ruiz-Gutierrez, M., & Borden, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2677 · Cited by 267 · see citing works

Prognostic Role of <i>PIK3CA</i> Mutation in Colorectal Cancer: Cohort Study and Literature Review

Liao, X., Morikawa, T., Lochhead, P., Imamura, Y., Kuchiba, A., Yamauchi, M., Nosho, K., Qian, Z. R., Nishihara, R., Meyerhardt, J. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2410 · Cited by 258 · see citing works

Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly

Kaizuka, T., Hara, T., Oshiro, N., Kikkawa, U., Yonezawa, K., Takehana, K., Iemura, S.-I., Natsume, T., & Mizushima, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121699 · Cited by 255 · see citing works

Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology

Ellis, L. M., & Hicklin, D. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1070 · Cited by 248 · see citing works

Direct Inhibition of GSK3β by the Phosphorylated Cytoplasmic Domain of LRP6 in Wnt/β-Catenin Signaling

Piao, S., Lee, S., Kim, H., Yum, S., Stamos, J. L., Xu, Y., Lee, S. J., Lee, J., Oh, S., Han, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004046 · Cited by 212 · see citing works

Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas

Fearnhead, N. S., Wilding, J. L., WINNEY, B. J., Tonks, S., Bartlett, S., Bicknell, D., Tomlinson, I. P. M., Mortensen, N. J. M., & Bodmer, W. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407187101 · Cited by 196 · see citing works

Dishevelled Promotes Wnt Receptor Degradation through Recruitment of ZNRF3/RNF43 E3 Ubiquitin Ligases

Jiang, X., Charlat, O., Zamponi, R., Yang, Y., & Cong, F. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.015 · Cited by 192 · see citing works

WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification

Coombs, G., Yu, J., Canning, C., Veltri, C. A., Covey, T. M., Cheong, J. K., Utomo, V., Banerjee, N., Zhang, Z., Jadulco, R. C., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.072132 · Cited by 191 · see citing works

PTEN Mutational Spectra, Expression Levels, and Subcellular Localization in Microsatellite Stable and Unstable Colorectal Cancers

Zhou, X.-P., Loukola, A., Salovaara, R., Nyström, M., Peltomäki, P., de la Chapelle, A., Aaltonen, L. A., & Eng, C. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64200-9 · Cited by 185 · see citing works

Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability.

Duval, A., Gayet, J., Zhou, X., Iacopetta, B. M., Thomas, G. D., & Hamelin, R. (1999) · PubMed · Cited by 182 · see citing works

Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney

Pearce, L. R., Sommer, E. M., Sakamoto, K., Wullschleger, S., & Alessi, D. R. (2011) · Biochemical Journal · doi:10.1042/bj20102103 · Cited by 179 · see citing works

Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer

Arqués, O., Chicote, I., Puig, I., Tenbaum, S. P., Argilés, G., Dienstmann, R., Fernández, N., Caratù, G., Matito, J., Silberschmidt, D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3081 · Cited by 179 · see citing works

β-Catenin destruction complex-independent regulation of Hippo–YAP signaling by APC in intestinal tumorigenesisPreprint

Cai, J., Maitra, A., Anders, R. A., Taketo, M. M., & Pan, D. (2015) · Genes & Development · doi:10.1101/gad.264515.115 · Cited by 175 · see citing works

Site-Specific mTOR Phosphorylation Promotes mTORC1-Mediated Signaling and Cell Growth

Acosta-Jaquez, H. A., Keller, J. A., Foster, K. G., Üstünel, B. E., Soliman, G. A., Feener, E. P., Ballif, B. A., & Fingar, D. C. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01665-08 · Cited by 167 · see citing works

Novel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth

Waaler, J., Machoň, O., von Kries, J. P., Wilson, S. R., Lundenes, E., Wedlich, D., Gradl, D., Paulsen, J. E., Machoňová, O., Dembinski, J. L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1282 · Cited by 165 · see citing works

Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in Apc Δ716 mice

Fujishita, T., Aoki, K., Lane, H. A., Aoki, M., & Taketo, M. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800041105 · Cited by 162 · see citing works

Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors.

Larsson, O., Li, S.-N., Issaenko, O. A., Avdulov, S. V., Peterson, M., Smith, K. A., Bitterman, P., & Polunovsky, V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0752 · Cited by 162 · see citing works

Inhibition of Mammalian Target of Rapamycin Induces Phosphatidylinositol 3-Kinase-Dependent and Mnk-Mediated Eukaryotic Translation Initiation Factor 4E Phosphorylation

Wang, X., Yue, P., Chan, C. B., Ye, K., Ueda, T., Watanabe‐Fukunaga, R., Fukunaga, R., Fu, H., Khuri, F. R., & Sun, S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00760-07 · Cited by 149 · see citing works

Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function

Lim, S., Saw, T. Y., Zhang, M., Janes, M. R., Nacro, K., Hill, J., Lim, A. Q., Chang, C.-T., Fruman, D. A., Rizzieri, D. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301838110 · Cited by 146 · see citing works

mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-dependent Foxk1 Phosphorylation

He, L., Gomes, A. P., Wang, X., Yoon, S. O., Lee, G., Nagiec, M. J., Cho, S., Chavez, A., Islam, T., Yu, Y., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.04.024 · Cited by 145 · see citing works

PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival

Rosty, C., Young, J. P., Walsh, M. D., Clendenning, M., Sanderson, K., Walters, R., Parry, S., Jenkins, M. A., Win, A. K., Southey, M. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065479 · Cited by 145 · see citing works

Complex Formation of Adenomatous Polyposis Coli Gene Product and Axin Facilitates Glycogen Synthase Kinase-3β-dependent Phosphorylation of β-Catenin and Down-regulates β-Catenin

Hinoi, T., Yamamoto, H., Kishida, M., Takada, S., Kishida, S., & Kikuchi, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003997200 · Cited by 136 · see citing works

Kinetic Responses of β-Catenin Specify the Sites of Wnt Control

Hernandez, A., Klein, A. M., & Kirschner, M. W. (2012) · Science · doi:10.1126/science.1228734 · Cited by 134 · see citing works

Pivotal role for glycogen synthase kinase–3 in hematopoietic stem cell homeostasis in mice

Huang, J. Y., Zhang, Y., Bersenev, A., O’Brien, W. T., Tong, W., Emerson, S. G., & Klein, P. S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40572 · Cited by 131 · see citing works

Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling

Proffitt, K. D., & Virshup, D. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.381970 · Cited by 127 · see citing works

DNA Sequence Profiles of the Colorectal Cancer Critical Gene Set KRAS-BRAF-PIK3CA-PTEN-TP53 Related to Age at Disease Onset

Berg, M., Danielsen, S. A., Ahlquist, T. C., Merok, M. A., Ågesen, T. H., Vatn, M. H., Mala, T., Sjo, O. H., Bakka, A. O., Moberg, I. O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013978 · Cited by 125 · see citing works

PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer

Day, F. L., Jorissen, R. N., Lipton, L. R., Mouradov, D., Sakthianandeswaren, A., Christie, M., Li, S., Tsui, C., Tie, J., Desai, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3614 · Cited by 125 · see citing works

First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer

Shapiro, G. I., Bell‐McGuinn, K. M., Molina, J. R., Bendell, J. C., Spicer, J. F., Kwak, E. L., Pandya, S. S., Millham, R., Borzillo, G. V., Pierce, K. J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1306 · Cited by 123 · see citing works

Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis

Guanti, G. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.283 · Cited by 123 · see citing works

Targeting PI3K Signaling as a Therapeutic Approach for Colorectal Cancer

Zhang, J., Roberts, T. M., & Shivdasani, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.010 · Cited by 121 · see citing works

The Oncogene eIF4E: Using Biochemical Insights to Target Cancer

Carroll, M. P., & Borden, K. L. B. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0142 · Cited by 110 · see citing works

A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer

Bendell, J. C., Varghese, A. M., Hyman, D. M., Bauer, T. M., Pant, S., Callies, S., Lin, J., Martínez, R., Wickremsinhe, E. R., Fink, A. A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3421 · Cited by 110 · see citing works

Tankyrase Inhibition Causes Reversible Intestinal Toxicity in Mice with a Therapeutic Index < 1

Zhong, Y., Katavolos, P., Nguyen, T., Lau, T., Boggs, J. W., Sambrone, A., Kan, D., Merchant, M. A., Harstad, E. B., Diaz, D., et al. (2015) · Toxicologic Pathology · doi:10.1177/0192623315621192 · Cited by 104 · see citing works

A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors

Bendell, J. C., Kurkjian, C. D., Infante, J. R., Bauer, T. M., Burris, H. A., Greco, F. A., Shih, K. C., Thompson, D. S., Lane, C. M., Finney, L. H., et al. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0218-6 · Cited by 101 · see citing works

Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors.

Avizienyte, E., Roth, S., Loukola, A., Hemminki, A., Lothe, R. A., Stenwig, A. E., Fosså, S. D., Salovaara, R., & Aaltonen, L. A. (1998) · PubMed · Cited by 101 · see citing works

APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway

Saito‐Diaz, K., Benchabane, H., Tiwari, A., Tian, A., Li, B., Thompson, J. J., Hyde, A. S., Sawyer, L. M., Jodoin, J. N., Santos, E., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.02.013 · Cited by 98 · see citing works

Adenomatous Polyposis Coli (APC) Regulates Multiple Signaling Pathways by Enhancing Glycogen Synthase Kinase-3 (GSK-3) Activity

Valvezan, A. J., Zhang, F., Diehl, J. A., & Klein, P. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323337 · Cited by 96 · see citing works

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245409 (XL765), a Novel, Orally Administered PI3K/mTOR Inhibitor in Patients with Advanced Solid Tumors

Papadopoulos, K. P., Tabernero, J. M., Markman, B., Patnaik, A., Tolcher, A. W., Baselga, J. M., Shi, W., Égile, C., Ruiz-Soto, R., Laird, A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2403 · Cited by 96 · see citing works

Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth

Wang, Q., Zhou, Y., Rychahou, P. G., Harris, J. W., Zaytseva, Y. Y., Liu, J., Wang, C., Weiss, H. L., Liu, C., Lee, E. Y., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3107 · Cited by 93 · see citing works

Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer.

Dong, S. M., Kim, K. M., Kim, S. Y., Shin, M. S., Na, E. Y., Lee, S. H., Park, W. S., Yoo, N. J., Jang, J. J., Yoon, C. Y., et al. (1998) · PubMed · Cited by 89 · see citing works

Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.

Berkel, H. J., Turbat‐Herrera, E. A., Shi, R., & Benedetti, A. D. (2001) · PubMed · Cited by 87 · see citing works

PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers

Zhong, Z., Sepramaniam, S., Chew, X. H., Wood, K. C., Lee, M. A., Madan, B., & Virshup, D. M. (2019) · Oncogene · doi:10.1038/s41388-019-0908-1 · Cited by 86 · see citing works

mTORC1 signaling suppresses Wnt/β-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level

Zeng, H., Lu, B., Zamponi, R., Yang, Z., Wetzel, K., Loureiro, J., Mohammadi, S., Beibel, M., Bergling, S., Reece-Hoyes, J. S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808575115 · Cited by 82 · see citing works

PIK3CA and APC mutations are synergistic in the development of intestinal cancers

Deming, D. A., Leystra, A. A., Nettekoven, L. A., Sievers, C. K., Miller, D. L., Middlebrooks, M., Clipson, L. J., Albrecht, D. M., Bacher, J. W., Washington, M. K., et al. (2013) · Oncogene · doi:10.1038/onc.2013.167 · Cited by 78 · see citing works

Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens

Ng, K., Tabernero, J. M., Hwang, J. J., Bajetta, E., Sharma, S., Prete, S. A. D., Arrowsmith, E. R., Ryan, D. P., Šedová, M., Jin, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0027 · Cited by 73 · see citing works

Detection of point mutations of the Axin1 gene in colorectal cancers

Jin, L., Shao, Q., Luo, W., Ye, Z., Li, Q., & Lin, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11435 · Cited by 68 · see citing works

Wnt pathway activation by ADP-ribosylation

Yang, E., Tacchelly‐Benites, O., Wang, Z., Randall, M. P., Tian, A., Benchabane, H., Freemantle, S. J., Pikielny, C. W., Tolwinski, N. S., Lee, E. N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11430 · Cited by 67 · see citing works

mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3β

Bautista, S. J., Boras, I., Vissa, A., Mecica, N., Yip, C. M., Kim, P. K., & Antonescu, C. N. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002800 · Cited by 67 · see citing works

Pharmacological interventions in the Wnt pathway: inhibition of Wnt secretion versus disrupting the protein–protein interfaces of nuclear factors

Zimmerli, D., Hausmann, G., Cantù, C., & Basler, K. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13864 · Cited by 66 · see citing works

Activation of WNT/β‐catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations

Park, Y., Kim, H., Cho, Y., Min, D., Cheon, S., Lim, Y., Song, S., Kim, S. J., Han, S., Park, K. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31662 · Cited by 65 · see citing works

Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations

Foley, T. M., Payne, S. N., Pasch, C. A., Yueh, A. E., Hey, D. R. V. D., Korkos, D. P., Clipson, L. J., Maher, M. E., Matkowskyj, K. A., Newton, M. A., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0256 · Cited by 62 · see citing works

Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions

Picco, G., Petti, C., Centonze, A., Torchiaro, E., Crisafulli, G., Novara, L., Acquaviva, A., Bardelli, A., & Médico, E. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606773 · Cited by 61 · see citing works

Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APCMin/+ mice

Koehl, G. E., Spitzner, M., Ousingsawat, J., Schreiber, R., Geissler, E. K., & Kunzelmann, K. (2009) · Oncogene · doi:10.1038/onc.2009.435 · Cited by 59 · see citing works

PTEN gene mutations in colorectal cancers displaying microsatellite instability

Shin, K. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00691-7 · Cited by 59 · see citing works

Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma

Spindler, K. G., Mau‐Sørensen, M., Pallisgaard, N., Andersen, R. F., Havelund, B. M., Pløen, J., Lassen, U., & Jakobsen, A. K. M. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.776175 · Cited by 59 · see citing works

Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer

Isinger-Ekstrand, A., Jönsson, M., Lindblom, A., Borg, Å., & Nilbert, M. C. (2009) · Familial Cancer · doi:10.1007/s10689-009-9293-1 · Cited by 55 · see citing works

mTORC1 Inactivation Promotes Colitis-Induced Colorectal Cancer but Protects from APC Loss-Dependent Tumorigenesis

Brandt, M., Grazioso, T. P., Fawal, M.-A., Tummala, K. S., Torres-Ruiz, R., Rodríguez, S., Perna, C., & Djouder, N. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.006 · Cited by 53 · see citing works

Colorectal carcinomas and PTEN/MMAC1 gene mutations.

Dicuonzo, G., Angeletti, S., García‐Foncillas, J., Brugarolas, A., Okrouzhnov, Y., Santini, D., Tonini, G., Lorino, G., Cesaris, M. D., & Baldi, A. (2001) · PubMed · Cited by 53 · see citing works

TANKYRASE Inhibition Enhances the Antiproliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting β-CATENIN and AKT Signaling in Colorectal Cancer

Solberg, N. T., Waaler, J., Lund, K., Mygland, L., Olsen, P. A., & Krauss, S. J. K. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0362 · Cited by 49 · see citing works

Development and applications of a beta-catenin oligonucleotide microarray: beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability.

Kim, I.-J., Kang, H. C., Park, J.-H., Shin, Y. S., Ku, J., Lim, S., Park, S. Y., Jung, S. Y., Kim, H. K., & Park, J. (2003) · PubMed · Cited by 49 · see citing works

Maintaining Glycogen Synthase Kinase-3 Activity Is Critical for mTOR Kinase Inhibitors to Inhibit Cancer Cell Growth

Koo, J., Yue, P., Gal, A. A., Khuri, F. R., & Sun, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2946 · Cited by 48 · see citing works

Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy

Li, Z., Sun, Y., Qu, M., Wan, H., Cai, F., & Zhang, P. (2016) · Oncotarget · doi:10.18632/oncotarget.13772 · Cited by 45 · see citing works

The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance

Quackenbush, K. S., Bagby, S. M., Tai, W. M. D., Messersmith, W. A., Schreiber, A., Greene, J., Kim, J., Wang, G., Purkey, A., Pitts, T. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8626 · Cited by 43 · see citing works

Rapamycin Inhibition of Polyposis and Progression to Dysplasia in a Mouse Model

Hardiman, K. M., Liu, J., Feng, Y., Greenson, J. K., & Fearon, E. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096023 · Cited by 41 · see citing works

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers

Fricke, S. L., Payne, S. N., Favreau, P. F., Kratz, J. D., Pasch, C. A., Foley, T. M., Yueh, A. E., Hey, D. R. V. D., Depke, M. G., Korkos, D. P., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0510 · Cited by 41 · see citing works

Novel mutations of the suppressor genePTENin colorectal carcinomas stratified by microsatellite instability- andTP53mutation- status

Danielsen, S. A., Lind, G. E., Bjørnslett, M., Meling, G. I., Rognum, T. O., Heim, S., & Lothe, R. A. (2008) · Human Mutation · doi:10.1002/humu.20860 · Cited by 41 · see citing works

GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors

Thorne, C. A., Wichaidit, C., Coster, A. D., Posner, B. A., Wu, L. F., & Altschuler, S. J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1690 · Cited by 37 · see citing works

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations

Moon, J.-H., Hong, S., Kim, J. E., Shin, J.-S., Kim, J.-S., Jung, S.-A., Ha, S. H., Lee, S., Kim, J., Lee, D. H., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0434-5 · Cited by 34 · see citing works

mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer

Mashima, T., Taneda, Y., Jang, M.-K., Mizutani, A., Muramatsu, Y., Yoshida, H., Sato, A., Tanaka, N., Sugimoto, Y., & Seimiya, H. (2017) · Oncotarget · doi:10.18632/oncotarget.18146 · Cited by 31 · see citing works

Oncogenic mutations in adenomatous polyposis coli (Apc) activate mechanistic target of rapamycin complex 1 (mTORC1)in mice and zebrafish

Valvezan, A. J., Huang, J. Y., Lengner, C. J., Pack, M. A., & Klein, P. S. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012625 · Cited by 29 · see citing works

Overexpression of eIF4E in colorectal cancer patients is associated with liver metastasis

Li, L., Xu, T., Zong, Y., Peng, L., Kong, S., Zhou, M., Zou, J., Liu, J., Miao, R., & Sun, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s98330 · Cited by 29 · see citing works

T-cell factor-4 frameshift mutations occur frequently in human microsatellite instability-high colorectal carcinomas but do not contribute to carcinogenesis.

Ruckert, S., Hiendlmeyer, E., Brueckl, W. M., Oswald, U., Beyser, K., Dietmaier, W., Haynl, A., Koch, C., Rüschoff, J., Brabletz, T., et al. (2002) · PubMed · Cited by 28 · see citing works

Regulation of GSK3 cellular location by FRAT modulates mTORC1-dependent cell growth and sensitivity to rapamycin

He, L., Fei, D. L., Nagiec, M. J., Mutvei, A. P., Lamprakis, A. A., Kim, B. Y., & Blenis, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902397116 · Cited by 25 · see citing works

Understanding How Wnt Influences Destruction Complex Activity and β-Catenin Dynamics

Mukherjee, A., Dhar, N., Stathos, M., Schaffer, D. V., & Kane, R. S. (2018) · iScience · doi:10.1016/j.isci.2018.07.007 · Cited by 24 · see citing works

Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies

Russo, M., Lamba, S., Lorenzato, A., Sogari, A., Corti, G., Rospo, G., Mussolin, B., Montone, M., Lazzari, L., Arena, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04506-z · Cited by 20 · see citing works

APC Moonlights to Prevent Wnt Signalosome Assembly

McGough, I. J., & Vincent, J. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.02.018 · Cited by 9 · see citing works

Butyrate producers, “The Sentinel of Gut”: Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics

Singh, V., Lee, G., Son, H., Koh, H., Kim, E. S., Unno, T., & Shin, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1103836 · Cited by 745 · see citing works

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy

Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546 · see citing works

RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target

Chen, H., Gao, S., Liu, W., Wong, C.-C., Wu, J., Wu, J., Liu, D., Gou, H., Kang, W., Zhai, J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.013 · Cited by 308 · see citing works

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment

Leiphrakpam, P., & Are, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063178 · Cited by 193 · see citing works

Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer

Akbarzadeh, M., Mihanfar, A., Akbarzadeh, S., Yousefi, B., & Majidinia, M. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119984 · Cited by 110 · see citing works

THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer

Zhou, X., Han, J., Zuo, A., Ba, Y., Liu, S., Xu, H., Zhang, Y., Weng, S., Zhou, Z., Liu, L., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02180-y · Cited by 110 · see citing works

Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells

Silva, V. R., Santos, L. D. S., Dias, R. B., Quadros, C. A., & Bezerra, D. P. (2021) · 癌症：英文版 · doi:10.1002/cac2.12235 · Cited by 106 · see citing works

A Comprehensive View on the Quercetin Impact on Colorectal Cancer

Neamțu, A.-A., Maghiar, T.-A., Alaya, A., Oláh, N.-K., Turcuș, V., Constanta, P. D., Totolici, B. D., Neamţu, C., Maghiar, A. M., & Máthé, E. (2022) · Molecules · doi:10.3390/molecules27061873 · Cited by 82 · see citing works

Brain endothelial PTEN/AKT/NEDD4-2/MFSD2A axis regulates blood-brain barrier permeability

Cui, Y., Wang, Y., Song, X., Ning, H., Zhang, Y., Teng, Y., Wang, J., & Yang, X. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109327 · Cited by 75 · see citing works

Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review)

Ji, Y., Lv, J., Sun, D., & Huang, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5056 · Cited by 70 · see citing works

Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?

Senthilathiban, D. P., Biswas, I., Kuduvalli, S. S., & Anitha, T. S. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110350 · Cited by 68 · see citing works

Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN

Codrich, M., Dalla, E., Mio, C., Antoniali, G., Malfatti, M. C., Marzinotto, S., Pierobon, M., Baldelli, E., Loreto, C. D., Damante, G., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01986-8 · Cited by 62 · see citing works

Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach

Wang, Y., Zhao, T. T., Huang, C., Liu, F., Zhang, Y., Kong, D., & Fan, Z. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155174 · Cited by 55 · see citing works

To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway

Zhong, J., Ding, S., Zhang, X., Di, W., Wang, X., Zhang, H., Chen, Y., Zhang, Y., & Hu, Y. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2802037 · Cited by 54 · see citing works

Therapeutic Applications of Nanoformulated Resveratrol and Quercetin Phytochemicals in Colorectal Cancer—An Updated Review

Meenakshi, D. U., Narde, G. K., Ahuja, A., Balushi, K. A. A., Francis, A. P., & Khan, S. A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060761 · Cited by 53 · see citing works

Re-establishing the comprehension of phytomedicine and nanomedicine in inflammation-mediated cancer signaling

Jha, N. K., Arfin, S., Jha, S. K., Kar, R., Dey, A., Gundamaraju, R., Ashraf, G. M., Gupta, P. K., Dhanasekaran, S., Abomughaid, M. M., et al. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.022 · Cited by 51 · see citing works

Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance

Ellakwa, D. E., Mushtaq, N., Khan, S., Jabbar, A., Abdelmalek, M. A., Wadan, A. S., Ellakwa, T. E., & Raza, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03076-w · Cited by 51 · see citing works

Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited

Hall, D. C. N., & Benndorf, R. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04430-y · Cited by 47 · see citing works

Interplay between Signaling Pathways and Tumor Microenvironment Components: A Paradoxical Role in Colorectal Cancer

Hamouda, S. B., & Essafi‐Benkhadir, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065600 · Cited by 47 · see citing works

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 53 · see citing works

Therapeutic potentials and targeting strategies of quercetin on cancer cells: Challenges and future prospects

Udaya Rajesh, R., & Sangeetha, D. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155902 · Cited by 45 · see citing works

The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies

Wang, H., Tang, R., Ling, J., & Jia, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1494802 · Cited by 45 · see citing works

Identifying key regulators of the intestinal stem cell niche

Duckworth, C. A. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210223 · Cited by 46 · see citing works

Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views

Kim, M. J., Huang, Y., & Park, J. (2020) · Cancers · doi:10.3390/cancers12123638 · Cited by 39 · see citing works

Progress Update in Pediatric Renal Tumors

Jain, J., Sutton, K. S., & Hong, A. L. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01016-y · Cited by 39 · see citing works

Immunopeptidomic Analyses of Colorectal Cancers With and Without Microsatellite Instability

Cleyle, J., Hardy, M., Minati, R., Courcelles, M., Durette, C., Lanoix, J., Laverdure, J., Vincent, K., Perreault, C., & Thibault, P. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100228 · Cited by 37 · see citing works

Interaction of the AKT and β-catenin signalling pathways and the influence of photobiomodulation on cellular signalling proteins in diabetic wound healing

Jere, S. W., Abrahamse, H., & Houreld, N. N. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00974-8 · Cited by 36 · see citing works

Zebrafish Cancer Predisposition Models

Kobar, K., Collett, K., Prykhozhij, S. V., & Berman, J. N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660069 · Cited by 32 · see citing works

Cohesin mutations are synthetic lethal with stimulation of WNT signaling

Chin, C. V., Antony, J., Ketharnathan, S., Labudina, A. A., Gimenez, G., Parsons, K. M., He, J.-S., George, A. J., Pallotta, M. M., Musio, A., et al. (2020) · eLife · doi:10.7554/elife.61405 · Cited by 30 · see citing works

Application of Nanotechnology and Phytochemicals in Anticancer Therapy

Kim, J. H., Dareowolabi, B. O., Thiruvengadam, R., & Moon, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091169 · Cited by 30 · see citing works

Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts

Wu, Z., Yin, B., & You, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.820474 · Cited by 29 · see citing works

Comprehensive Insights Into the Combinatorial Uses of Selected Phytochemicals in Colorectal Cancer Prevention and Treatment: Isothiocyanates, Quinones, Carotenoids, and Alkaloids

Deng, X., Yang, Z., Han, M., Ismail, N., Esa, N. M., Razis, A. F. A., Bakar, M. Z. A., & Chan, K. W. (2024) · Phytotherapy Research · doi:10.1002/ptr.8378 · Cited by 28 · see citing works

Neural signaling modulates metabolism of gastric cancer

Rabben, H.-L., Andersen, G. T., Olsen, M. K., Øverby, A., Ianevski, A., Kainov, D. E., Wang, T. C., Lundgren, S., Grønbech, J. E., Chen, D., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102091 · Cited by 28 · see citing works

The application of extracellular vesicles in colorectal cancer metastasis and drug resistance: recent advances and trends

Xiong, L., Wei, Y., Jia, Q., Chen, J., Chen, T., Yuan, J., Pi, C., Liu, H., Tang, J., Yin, S., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01888-1 · Cited by 29 · see citing works

Fusobacterium nucleatum modulates the Wnt/β-catenin pathway in colorectal cancer development

Mondal, T., Chattopadhyay, D., Mondal, P. S., Das, S., Mondal, A., Das, A., Samanta, S., & Saha, T. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140196 · Cited by 27 · see citing works

KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics

Voutsadakis, I. A. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.103987 · Cited by 28 · see citing works

Regulation of SIRT2 by Wnt/β-catenin signaling pathway in colorectal cancer cells

Li, C., Zhou, Y., Kim, J. T., Sengoku, T., Alstott, M. C., Weiss, H. L., Wang, Q., & Evers, B. M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118966 · Cited by 26 · see citing works

Roles of Src family kinase, Ras, and mTOR signaling in intestinal epithelial homeostasis and tumorigenesis

Matozaki, T., Kotani, T., Murata, Y., & Saito, Y. (2020) · Cancer Science · doi:10.1111/cas.14702 · Cited by 26 · see citing works

The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance

Chen, Z., Wang, G., Guo, M., Zhu, N., Chen, X., Yan, Y., Li, N., & Yu, W. (2024) · Cancer Control · doi:10.1177/10732748241274196 · Cited by 24 · see citing works

Has-miR-129-5p’s Involvement in Different Disorders, from Digestive Cancer to Neurodegenerative Diseases

Boicean, A., Bîrsan, S., Ichim, C., Boeraș, I., Roman-Filip, I., GRAMA, B. G., Bacila, C. I., Fleacă, R. S., Dura, H., & Roman-Filip, C. (2023) · Biomedicines · doi:10.3390/biomedicines11072058 · Cited by 22 · see citing works

HOTAIR Promotes the Hyperactivation of PI3K/Akt and Wnt/β-Catenin Signaling Pathways via PTEN Hypermethylation in Cervical Cancer

Trujano-Camacho, S., de León, D. F. C., Pérez-Yépez, E. A., Contreras-Romero, C., Coronel-Hernández, J., Millán-Catalán, O., Rodríguez‐Dorantes, M., López‐Camarillo, C., Gutiérrez‐Ruíz, M. C., Jacobo-Herrera, N. J., et al. (2024) · Cells · doi:10.3390/cells13171484 · Cited by 24 · see citing works

Bioactive spermidine nanoparticles for effective cardiovascular recovery and diabetic therapy

Nie, T., Fang, Z., Liu, H., Zhang, X., Fang, Y., Xu, X., Huang, H. W., & Wu, J. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137353 · Cited by 21 · see citing works

Molecular explanation of Wnt/βcatenin antagonist pyrvinium mediated calcium equilibrium changes in aging cardiovascular disorders

Alharbi, K. S., Singh, Y. P., Afzal, O., Altamimi, A. S. A., Kazmi, I. A., Al-Abbasi, F. A., Alzarea, S. I., Chellappan, D. K., Singh, S. K., Dua, K., et al. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07863-7 · Cited by 21 · see citing works

Unraveling the complexities of colorectal cancer and its promising therapies – An updated review

Saha, S., Ghosh, S., Ghosh, S., Nandi, S., & Nayak, A. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113325 · Cited by 23 · see citing works

High-fat diet plus HNF1A variant promotes polyps by activating β-catenin in early-onset colorectal cancer

Song, H., Sontz, R. A., Vance, M. J., Morris, J. M., Sheriff, S., Zhu, S., Duan, S., Zeng, J., Koeppe, E. S., Pandey, R., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167163 · Cited by 20 · see citing works

Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis

Kim, C. G., Terado, T., Tambe, Y., Mukaisho, K., Kageyama, S., Kawauchi, A., & Inoue, H. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5220 · Cited by 18 · see citing works

Metalloprotease ADAM9 cleaves ephrin-B ligands and differentially regulates Wnt and mTOR signaling downstream of Akt kinase in colorectal cancer cells

Chandrasekera, P., Perfetto, M., Lu, C., Zhuo, M., Bahudhanapati, H., Li, J., Chen, W.-C., Kulkarni, P., Christian, L., Liu, J., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102225 · Cited by 18 · see citing works

Transmembrane and coiled-coil domain family 3 (TMCC3) regulates breast cancer stem cell and AKT activation

Wang, Y., Chan, Y., Hung, T., Hung, J., Kuo, M.-W., Wang, S., Huang, Y., Lin, Y., Chen, S., Yu, J., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01729-1 · Cited by 18 · see citing works

A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response

Sharma, U., Murmu, M., Barwal, T. S., Tuli, H. S., Jain, M., Prakash, H., Kaceli, T., Jain, A., & Bishayee, A. (2022) · Current Oncology · doi:10.3390/curroncol29040189 · Cited by 17 · see citing works

Inhibition of Dickkopf-1 enhances the anti-tumor efficacy of sorafenib via inhibition of the PI3K/Akt and Wnt/β-catenin pathways in hepatocellular carcinoma

Seo, S. H., Cho, K. J., Park, H. J., Lee, H. W., Kim, B. K., Park, J. Y., Kim, D. Y., Ahn, S. H., Cheon, J. H., Yook, J. I., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01355-2 · Cited by 17 · see citing works

Predisposition Footprints in the Somatic Genome of Wilms Tumors

Treger, T. D., Wegert, J., Wenger, A., Coorens, T. H. H., Al‐Saadi, R., Kemps, P. G., Kennedy, J., Parks, C., Anderson, N. D., Hodder, A., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0878 · Cited by 16 · see citing works

Propofol inhibits colon cancer cell stemness and epithelial-mesenchymal transition by regulating SIRT1, Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways

Wang, R., Li, S., Hou, Q., Zhang, B., Chu, H., Hou, Y., Ni, C., Sun, L., Ran, Y., & Zheng, H. (2023) · Discover Oncology · doi:10.1007/s12672-023-00734-y · Cited by 16 · see citing works

Molecular Signaling Pathways of Quercetin in Alzheimer’s Disease: A Promising Arena

Alsaleem, M. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Alrouji, M., Yassen, A. S. A., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01526-w · Cited by 16 · see citing works

Strategies for overcoming ABC transporter-mediated multidrug resistance in colorectal cancer

de Groot, R. A., Reedijk, D., Faucher, Q., Mihaila, S. M., & Masereeuw, R. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00412.2025 · Cited by 15 · see citing works

Anti-tumour effect of Huangqin Decoction on colorectal cancer mice through microbial butyrate mediated PI3K/Akt pathway suppression

Zhu, J., Liu, H., Yang, L., Fang, Z., Fu, R., Chen, J., Liu, S., & Fei, B. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001692 · Cited by 15 · see citing works

In vitro and in vivo study on the osseointegration of magnesium and strontium ion with two different proportions of mineralized collagen and its mechanism

Sun, Y., Liu, H., Sun, X., Xia, W., & Deng, C. B. (2021) · Journal of Biomaterials Applications · doi:10.1177/08853282211016934 · Cited by 15 · see citing works

MsrB1 Promotes Proliferation and Invasion of Colorectal Cancer Cells via GSK-3β/β-catenin Signaling Axis

Chen, X., Yang, S., Ruan, X.-J., Ding, H., Wang, N.-X., Liu, F., Li, J., & Li, Y. (2021) · Cell Transplantation · doi:10.1177/09636897211053203 · Cited by 15 · see citing works

Single-Cell-Derived Tumor Organoid (STO) arrays on a microfluidic chip for personalized drug screening to address heterogeneity-induced drug resistance in colorectal cancer

Lin, D., Luo, Y., Chen, J., Ma, Z., Kang, H., Wang, X., Wang, L., & Liu, D. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-01068-1 · Cited by 14 · see citing works

Synthetic mRNAs; Their Analogue Caps and Contribution to Disease

Kyriakopoulos, A. M., & McCullough, P. A. (2021) · Diseases · doi:10.3390/diseases9030057 · Cited by 15 · see citing works

Cytoplasmic TRIM24 promotes colorectal cancer cell proliferation by activating Wnt/β-catenin signaling

Wang, Y., Yao, Y., Liu, Z., Long, S., Feng, Y., Fang, Q. Z., Wu, D., Zhu, Q., Zai, H., Xiao, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63685-8 · Cited by 14 · see citing works

The mechanisms of class 1A PI3K and Wnt/β-catenin coupled signaling in breast cancer

Rodgers, S. J., Mitchell, C. A., & Ooms, L. M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220866 · Cited by 13 · see citing works

Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer Patients

Pinto, M. P., Muñoz‐Medel, M., Retamal, I. N., Bravo, M. L., Latapiat, V., Córdova‐Delgado, M., Hill, C. N., Fernández, M. F., Sánchez, C., Sáez, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010001 · Cited by 13 · see citing works

Discovery and functional assessment of a novel adipocyte population driven by intracellular Wnt/β-catenin signaling in mammals

Zhi, L., Tian, C., Zhang, S., Yang, T., Gong, Y., Deng, H., Bai, D., Tian, W., & Chen, Y. (2022) · eLife · doi:10.7554/elife.77740 · Cited by 11 · see citing works

Marine actinobacterium Streptomyces vinaceusdrappus mediated nano-selenium: biosynthesis and biomedical activities

Ghareeb, A., Fouda, A., Kishk, R. M., & El-Kazzaz, W. M. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05073-9 · Cited by 12 · see citing works

Human T2D-Associated Gene <i>IMP2/IGF2BP2</i> Promotes the Commitment of Mesenchymal Stem Cells Into Adipogenic Lineage

Regué, L., Wang, W., Ji, F., Avruch, J., Wang, H., & Dai, N. (2023) · Diabetes · doi:10.2337/db21-1087 · Cited by 12 · see citing works

The role of Wnt/β-catenin signaling pathway in the pathogenesis and treatment of multiple myeloma (review).

(2021) · PubMed Central · Cited by 11 · see citing works

The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway

Li, H., Li, J., Zhang, Y., Zhao, C., Ge, J., Sun, Y., Fu, H., & Li, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1401979 · Cited by 11 · see citing works

A Comprehensive Review of Protein Biomarkers for Invasive Lung Cancer

Mezentsev, A., Durymanov, M. O., & Макаров, В. А. (2024) · Current Oncology · doi:10.3390/curroncol31090360 · Cited by 11 · see citing works

CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis

Evans, J. F., Obraztsova, K., Lin, S. M., & Krymskaya, V. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052233 · Cited by 11 · see citing works

Plant-derived molecules as multitarget modulators of NF-κB, PI3K/Akt, MAPK, and AMPK/mTOR signaling in chronic diseases

Modak, K., Dey, A., Bharti, K. K., Gautam, M. K., Mondal, S., Dutta, P. P., & Gangwar, M. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154097 · Cited by 10 · see citing works

Ivermectin represses Wnt/β-catenin signaling by binding to TELO2, a regulator of phosphatidylinositol 3-kinase-related kinases

Yonezawa, H., Ikeda, A., Takahashi, R., Endo, H., Sugawara, Y., Goto, M., Kanno, M., Ogawa, S., Nakamura, K., Ujiie, H., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103912 · Cited by 10 · see citing works

Human La Protein: An RNA-Binding Protein Involved in Ovarian Cancer Development and Multidrug Resistance

Huang, X., & Tang, J. Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s269983 · Cited by 10 · see citing works

The Genomic Environment of BRAF Mutated and BRAF/PIK3CA Double Mutated Colorectal Cancers

Voutsadakis, I. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175132 · Cited by 10 · see citing works

Combining multi‐omics analysis to identify host‐targeted targets for the control of Brucella infection

Yu, J., Yuan, H., Guo, J., Dong, Z., Li, S., Fu, Q., Aode, B., Baoyin, S., Bao, L., & Wu, L. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14307 · Cited by 9 · see citing works

Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer

Guo, Y., Zhang, Y., Cen, K., Dai, Y., Mai, Y., & Hong, K. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125203 · Cited by 8 · see citing works

Long non-coding RNA NEAT1 induced by BHLHE40 activates Wnt/β-catenin signaling and potentiates colorectal cancer progression

Ji, A., Li, H., Fu, X., Zhang, Y., & Liu, Y. (2024) · Cell Division · doi:10.1186/s13008-024-00129-7 · Cited by 8 · see citing works

Cell signaling communication within papillary craniopharyngioma revealed by an integrated analysis of single-cell RNA sequencing and bulk RNA sequencing

Zhu, X., Jia, Y., Zhao, Z., Zhang, X., Zhao, Y., Gui, S., & Yang, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06149-3 · Cited by 8 · see citing works

eIF3d and eIF4G2 mediate an alternative mechanism of cap-dependent but eIF4E-independent translation initiation

Quartey, J. N. K., & Goss, D. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108317 · Cited by 9 · see citing works

PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer

Yakkala, P. A., Naaz, F., Shafi, S., & Kamal, Ä. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2331015 · Cited by 8 · see citing works

ERMP1 Facilitates The Malignant Characteristics of Colorectal Cancer Cells through Modulating PI3K/AKT/β-Catenin Pathway and Localization of GRP78.

Rahmani-Kukia, N., Zamani, M., & Mokaram, P. (2023) · PubMed Central · doi:10.22074/cellj.2023.1982707.1188 · Cited by 8 · see citing works

Chronic NaAsO2 exposure promotes migration and invasion of prostate cancer cells by Akt/GSK-3β/β-catenin/TCF4 axis-mediated epithelial-mesenchymal transition

Zhang, Z., Yan, H.-X., Liu, M., Niu, F.-W., Yao, K., Feng, S., Li, X., Chen, Y., & Xie, D. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.117741 · Cited by 7 · see citing works

Navigating Glioma Complexity: The Role of Abnormal Signaling Pathways in Shaping Future Therapies

Chen, Q., Jin, J., Li, P., Wang, X., & Wang, Q. (2025) · Biomedicines · doi:10.3390/biomedicines13030759 · Cited by 7 · see citing works

Colon adenocarcinoma and Birt–Hogg–Dubé syndrome in a young patient: case report and exploration of pathologic implications

Jirka, G. W., Lefler, D. S., Russo, J. R., & Bashir, B. (2023) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2184153 · Cited by 7 · see citing works

HECW2 promotes the progression and chemoresistance of colorectal cancer via AKT/mTOR signaling activation by mediating the ubiquitin-proteasome degradation of lamin B1

Li, F., Wang, L., Wang, Y., Shen, H., Kou, Q., Shen, C., Xu, X., Zhang, Y., & Zhang, J. (2023) · Journal of Cancer · doi:10.7150/jca.87545 · Cited by 7 · see citing works

The role of physical activity and epigenetic changes in colorectal cancer prevention

Sun, Y., Keat, O. B., & Rajabi, S. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03872-1 · Cited by 7 · see citing works

Regulatory effect between HMGA2 and the Wnt/β‑catenin signaling pathway in the carcinogenesis of sporadic colorectal tubular adenoma

Li, D., Cao, Y., Wang, J., Yang, H., Liu, W., Cui, J., & Wu, W. (2021) · Oncology Letters · doi:10.3892/ol.2021.13110 · Cited by 7 · see citing works

Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in <scp>2D</scp> and <scp>3D</scp> Cell Culture Models

Serala, K., Bai, J., & Prince, S. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70222 · Cited by 6 · see citing works

The effect of novel nitrogen-based chalcone analogs on colorectal cancer cells: Insight into the molecular pathways

Hassan, A. F., Hussein, O., Al-Barazenji, T., Allouch, A., Kamareddine, L., Malki, A. M., Moustafa, A. A., & Khalil, A. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27002 · Cited by 6 · see citing works

4-O-Methylascochlorin Synergistically Enhances 5-Fluorouracil-Induced Apoptosis by Inhibiting the Wnt/β-Catenin Signaling Pathway in Colorectal Cancer Cells

Jo, M.-Y., Jeong, Y., Song, K., Choi, Y. H., Kwon, T. K., & Chang, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115746 · Cited by 6 · see citing works

Tyrosine phosphatase SHP2 promoted the progression of CRC via modulating the PI3K/BRD4/TFEB signaling induced ferroptosis

Chen, J., Li, W., Zhang, C., Wen, D., & Cheng, J. (2024) · Discover Oncology · doi:10.1007/s12672-024-01586-w · Cited by 6 · see citing works

Arsenic toxicity in Antarctic krill oil and its impact on human intestinal cells

Zhang, H., Ji, Y., Jiang, Z., Yang, G., Kong, C., Shen, Z., Yuan, T., & Shen, X. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.117680 · Cited by 6 · see citing works

Non-coding RNAs and exosomal ncRNAs in colorectal cancer

Zhoulideh, Y. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00646-2 · Cited by 6 · see citing works

Rational peptide design for targeting cancer cell invasion

Gomari, M. M., Arab, S. S., Balalaie, S., Ramezanpour, S., Hosseini, A., Dokholyan, N. V., & Tarighi, P. (2023) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26580 · Cited by 6 · see citing works

Transcriptomics analysis unveils key potential genes associated with brain development and feeding behavior in the hypothalamus of L-citrulline-fed broiler chickens

Uyanga, V. A., Bello, S. F., Qian, X., Chao, N., Li, H., Zhao, J., Wang, X., Jiao, H., Onagbesan, O. M., & Lin, H. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103136 · Cited by 6 · see citing works

PIK3CA mutation in a case of CTNNB1 -mutant sinonasal glomangiopericytomaPreprint

Hong, C. S., Khan, M., Sukys, J. M., Prasad, M. L., Erson-Omay, Z., Vining, E. M., & Omay, S. B. (2021) · Molecular Case Studies · doi:10.1101/mcs.a006120 · Cited by 6 · see citing works

From PIK3CA Mutations to Rational PI3K Inhibition for the Treatment of Colorectal Cancer

Voutsadakis, I. A. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-025-00815-4 · Cited by 5 · see citing works

Daily berry consumption attenuates β-catenin signalling and genotoxicity in colon carcinoma cells exposed to faecal water from healthy volunteers in a clinical trial

Slabá, H., Määttänen, M., Marttinen, M., Lapinkero, V., Päivärinta, E., & Pajari, A. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105440 · Cited by 5 · see citing works

Multi Omics Integration in Colorectal Cancer: From Molecular Insights to Precision Oncology

Liu, Z., Ang, M. Y., & Kue, C. S. (2026) · Cancers · doi:10.3390/cancers18101504 · Cited by 6 · see citing works

Transcriptomic Context of RUNX3 Expression in Monocytes: A Cross-Sectional Analysis

Dybska, E., Nowak, J. K., & Walkowiak, J. (2023) · Biomedicines · doi:10.3390/biomedicines11061698 · Cited by 4 · see citing works

IRS2 as a driver of brain metastasis in colorectal cancer: A potential target for novel therapeutic strategies

Greenberg, I., Khair, F., Merenbakh-Lamin, K., Sokol, E. S., Goldberg, A. K., Simkin, D., Spitzer, A., Benhamou, M., Bar-Shira, S., Raz, M. A., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf028 · Cited by 4 · see citing works

Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K/Akt/mTOR and Wnt Pathways

Pandurangan, A. K. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2201 · Cited by 198 · see citing works

Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status

Fleming-de-Moraes, C. D., Rocha, M. R., Tessmann, J. W., de Araújo, W. M., & Morgado‐Díaz, J. A. (2022) · Cancer Biology & Therapy · doi:10.1080/15384047.2022.2108690 · Cited by 82 · see citing works

Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review

Ma, S., Li, L., Cai, H., Guo, T., & Zhang, L. (2023) · World Journal of Clinical Oncology · doi:10.5306/wjco.v14.i2.81 · Cited by 18 · see citing works

PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence

Narayanankutty, A. (2019) · Current Drug Targets · doi:10.2174/1389450120666190618123846 · Cited by 264 · see citing works

PI3K and tankyrase inhibitors as therapeutic targets in colorectal cancer

Yakkala, P. A., Naaz, F., Shafi, S., & Kamal, Ä. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2331015 · Cited by 8 · see citing works